For past Congresses, use the Browse menu.

Expressing the sense of the House of Representatives that policies governing access to medication abortion care in the United States should be equitable and based on science.

Lobbying Summary

Organizations below reported lobbying activity that included this bill as a disclosed issue. Expand to view filing details.

Loading filings…